Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Brognard

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|April 24, 2015
Transcriptional Repressor DAXX Promotes Prostate Cancer Tumorigenicity via Suppression of AutophagyLorena A Puto, John Brognard, Tony Hunter
Oncotarget|August 22, 2013
Druggable drivers of lung cancerShameem Fawdar, Zoe C Edwards, John Brognard
Nature Cancer|August 16, 2024
Dual inhibition of EGFR and PI3K with a single drugMeghri Katerji, Maxine R Rubin, John Brognard
Molecular Cell|March 28, 2007
PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoformsJohn Brognard, Emma Sierecki, Tianyan Gao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 23, 2014
Reply: To PMID 23666743Alexandre Belot, John Brognard, Yanick J Crow, et al.
Cancer Research|April 14, 2011
Cancer-associated loss-of-function mutations implicate DAPK3 as a tumor-suppressing kinaseJohn Brognard, You-Wei Zhang, Lorena A Puto, et al.
Cancers|April 14, 2026
Tumor-Specific Pro-Thrombotic Gene Expression in Head and Neck Squamous Cell Carcinoma: A Multi-Cohort Transcriptomic AnalysisKiranya E Arnold, Nadia Debick, John Brognard, et al.
The Journal of Biological Chemistry|May 3, 2020
The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cellsVan T Hoang, Katherine Nyswaner, Pedro Torres-Ayuso, et al.
Journal of the American Chemical Society|January 30, 2003
Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase AktAlan P Kozikowski, Haiying Sun, John Brognard, et al.
The Journal of Biological Chemistry|March 28, 2009
Common polymorphism in the phosphatase PHLPP2 results in reduced regulation of Akt and protein kinase CJohn Brognard, Matthew Niederst, Gloria Reyes, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|April 24, 2015
Transcriptional Repressor DAXX Promotes Prostate Cancer Tumorigenicity via Suppression of AutophagyLorena A Puto, John Brognard, Tony Hunter
Oncotarget|August 22, 2013
Druggable drivers of lung cancerShameem Fawdar, Zoe C Edwards, John Brognard
Nature Cancer|August 16, 2024
Dual inhibition of EGFR and PI3K with a single drugMeghri Katerji, Maxine R Rubin, John Brognard
Molecular Cell|March 28, 2007
PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoformsJohn Brognard, Emma Sierecki, Tianyan Gao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 23, 2014
Reply: To PMID 23666743Alexandre Belot, John Brognard, Yanick J Crow, et al.
Cancer Research|April 14, 2011
Cancer-associated loss-of-function mutations implicate DAPK3 as a tumor-suppressing kinaseJohn Brognard, You-Wei Zhang, Lorena A Puto, et al.
Cancers|April 14, 2026
Tumor-Specific Pro-Thrombotic Gene Expression in Head and Neck Squamous Cell Carcinoma: A Multi-Cohort Transcriptomic AnalysisKiranya E Arnold, Nadia Debick, John Brognard, et al.
The Journal of Biological Chemistry|May 3, 2020
The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cellsVan T Hoang, Katherine Nyswaner, Pedro Torres-Ayuso, et al.
Journal of the American Chemical Society|January 30, 2003
Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase AktAlan P Kozikowski, Haiying Sun, John Brognard, et al.
The Journal of Biological Chemistry|March 28, 2009
Common polymorphism in the phosphatase PHLPP2 results in reduced regulation of Akt and protein kinase CJohn Brognard, Matthew Niederst, Gloria Reyes, et al.
Pageof 6